John N. Abelson

Founder at The Agouron Institute

Consumer Services

Health Technology

Profile

John N.
Abelson is the founder of Melinta Subsidiary Corp.
which was founded in 2000.
Dr. Abelson is also the founder of The Agouron Institute.
Currently, Dr. Abelson holds the position of Professor-Emeritus at California Institute of Technology.

John N. Abelson active positions

Companies	Position	Start
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.	Corporate Officer/Principal	-
The Agouron Institute	Founder	-

All active positions of John N. Abelson

Former positions of John N. Abelson

Companies	Position	End
Melinta Subsidiary Corp. Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT.	Founder	-

See the detail of John N. Abelson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John N. Abelson's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Melinta Subsidiary Corp. Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT.	Health Technology
The Agouron Institute